Revolution Medicines files patent for inhibiting RAS proteins for cancer treatment
Pharmaceutical Technology
MARCH 11, 2024
Discover how Revolution Medicines Inc. is revolutionizing cancer treatment with their patented macrocyclic compounds targeting Ras proteins. Learn more about their potential impact on various types of cancer and Ras mutations.
Let's personalize your content